WuXi Biologics is a leading
contract research, development and manufacturing organization providing end-to-end capabilities to healthcare organizations worldwide. With operations in the United States, Ireland, Germany, Singapore
and China, we enable our partners to effectively and efficiently bring
biologics and vaccines to patients worldwide through our comprehensive and
high-quality drug development model. WuXi
XDC and WuXi Vaccines, two subsidiaries of WuXi Biologics, offer end-to-end
platforms for the development and manufacture of bioconjugates and vaccines,
respectively.